BIO-key(R) Reports Profitability on Strong Revenue Growth for Second Qu... (d using the pass code 11117487#. Additio...)

BIO-key(R) Reports Profitability on Strong Revenue Growth for Second Quarter 2008

Date:8/10/2008

d using the pass code 11117487#. Additionally, an archive of the webcast will be available shortly after completion of the call on the Company's website (http://www.bio-key.com) for a period of three months.

About BIO-key

BIO-key International, Inc., headquartered in Wall, New Jersey, develops and delivers advanced identification solutions and information services to law enforcement departments, public safety agencies, government and private sector customers. BIO-key's mobile wireless technology provides first responders with critical, reliable, real-time data and images from local, state and national databases. BIO-key's high performance, scalable, cost-effective and easy-to-deploy biometric finger identification technology accurately identifies and authenticates users of wireless and enterprise data to improve security, convenience and privacy and to reduce identity theft. Over 750 police departments in North America use BIO-key solutions, making BIO-key the leading supplier of mobile and wireless solutions for law enforcement. (http://www.bio-key.com)

Certain statements contained in this press release may be construed as "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of these statements. These risks and uncertainties include, without limitation, our history of losses and limit
'/>"/>

SOURCE BIO-key International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5
Related biology news :

1. BIO-key(R) Announces Contracts for New Criminal Justice Data Sharing Solution
2. BIO-key(R) International to Showcase Deployed Biometric Security Applications at 2007 Biometric Technology Expo
3. Radiant Systems Selects BIO-key(R) Biometric Software for POS Solution
4. Radiant Systems Selects BIO-key(R) Biometric Software for POS Solution
5. BIO-key(R) International to Showcase Deployed Biometric Security Applications at 2007 Biometric Technology Expo
6. Youngstown, Ohio Police Award Mobile Data Contract to BIO-key(R) International
7. Easton, PA Police Officers Armed With BIO-key(R) Mobile Data Solution Access Information Anytime, Anywhere
8. BIO-key(R) PocketCop(R) Project Leading the Nation According to Televised Report
9. BIO-key(R) and Tiger IT Awarded a Follow-on Contract for Nationwide Voter / Citizen Registration in Bangladesh
10. Wireless Public Safety Solution From BIO-key(R) and DaProSystems Links Virginia Law Enforcement Agencies
11. BIO-key(R) Receives $344,000 Contract Award from Hawaii County

Post Your Comments:

(Date:12/3/2009)UPTON, NY A team of scientists from the U.S. Department of Energy,s (DOE) Brookhaven National Laboratory, Harvard University, and the Indian Institute of Science has made a major step in understandin

(Date:12/2/2009)PHILADELPHIA New study results strengthen the evidence that people who smoke cigarettes over a long period of time have an increased risk for developing colorectal cancer, even after adjusting for ot

(Date:12/2/2009)PHILADELPHIA Exposure to secondhand smoke for a prolonged period of time and in high quantity may increase the risk of breast cancer, even in women who never smoked cigarettes themselves. , "The qu

Breaking Biology News(10 mins):Grooving down the helix 2 Grooving down the helix 3 Cigarette smoking increases colorectal cancer risk 2 Exposure to secondhand cigarette smoke over a lifetime increased breast cancer risk later in life 2 Shire Reports Tolerability and Clinical Effects Results of Daytrana 28R 29 28methylphenidate transdermal system 29 from Study in Adolescents with ADH 5890 1 Shire Reports Tolerability and Clinical Effects Results of Daytrana 28R 29 28methylphenidate transdermal system 29 from Study in Adolescents with ADH 5890 2 Shire Reports Tolerability and Clinical Effects Results of Daytrana 28R 29 28methylphenidate transdermal system 29 from Study in Adolescents with ADH 5890 3 Shire Reports Tolerability and Clinical Effects Results of Daytrana 28R 29 28methylphenidate transdermal system 29 from Study in Adolescents with ADH 5890 4 Shire Reports Tolerability and Clinical Effects Results of Daytrana 28R 29 28methylphenidate transdermal system 29 from Study in Adolescents with ADH 5890 5 Shire Reports Tolerability and Clinical Effects Results of Daytrana 28R 29 28methylphenidate transdermal system 29 from Study in Adolescents with ADH 5890 6 Shire Reports Tolerability and Clinical Effects Results of Daytrana 28R 29 28methylphenidate transdermal system 29 from Study in Adolescents with ADH 5890 7 Gen Probe to Webcast Two Upcoming Investor Presentations 5888 1 Gen Probe to Webcast Two Upcoming Investor Presentations 5888 2 Patients More Likely to Die While in ICU in U S Than in England 60428 1 Patients More Likely to Die While in ICU in U S Than in England 60428 2

[0] Grooving down the helix [0] Cigarette smoking increases colorectal cancer risk [0] Exposure to secondhand cigarette smoke over a lifetime increased breast cancer risk later in life

...ommonwealth University Massey Cancer Center have f...ement of human breast cancer cells toward epiderma...nal of Biological Chemistry, researchers showed th... role in breast cancer progression, stimulates sph...nzymes that forms the potent lipid mediator, sphin...

...ar subtleties of a strain of mice engineered to ag...ion of genetic mutations prompts a cascade of prog... process. , Writing today (July 15, 2005) in the j...sity of Wisconsin-Madison geneticist Tomas A. Prol... normal mice that peel away some of the root secre...

...global health threat. Although more than 3 billion...o fight tuberculosis, the ability of the BCG vacci...ficacy against newly emerging isolates. , In a stu...nt publication of the September 1 issue of the Jou...d colleagues from the Max Planck Institute devise ...

Other Biology News:Elderly mice yield clues to the process of growing old 2 Elderly mice yield clues to the process of growing old 3

VCU Massey Cancer Center study shows enzyme linked to spread of breast cancer cells Elderly mice yield clues to the process of growing old Agilent Technologies Introduces First Commercial Mouse Microarray for Comparative Genomic Hybridization Research

(Date:12/2/2009)NEW YORK, Dec. 2 Reportlinker.com announces that a new market research report is available in its catalogue: ,, Drug Discovery Technologies - A Global Update of Market Trends & Opportunities ,,

(Date:12/2/2009)CALGARY, Dec. 2 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics" or the "Company") (TSX:ONC; NASDAQ: ONCY ) announced today that in connection with its previously announced unit offering

(Date:12/2/2009)JERUSALEM, Israel, December 2 Gamida Cell announced today,a feasibility study evaluating the preclinical (animal study) safety and,efficacy of a gene therapy product which combines technology from We

(Date:12/2/2009)QUEBEC CITY, Dec. 2 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS ; TSX: AEZ) (the "Company"), a global biopharmaceutical company focused on endocrine therapy and oncology, today annou

[0] Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities [0] Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option [0] Gamida Cell Announces Feasibility Study With Weill Cornell Medical College [0] AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma

...ons is pleased to welcome Richard Duffey, M.D., to...in Mobile, Alabama and also serves patients from P...and Pascagoula communities in Mississippi.,Trusted... LASIK Eye Surgeons directory service and informat...geons.com . What sets the Trusted LASIK Surgeons d...

...tion (OTC: MYMX), will be holding an important con... New York Time to update all shareholders,on the r...Form 10-Q and to,address recent press articles., ...866-591-4361 PIN 815,726 and from Europe at +41-80...Mymetics, primary objective is to develop vaccines...

...aqGS: VARI) introduced its new dual wavelength X-r...les and proteins. The SuperNova(TM) is the,first d...high intensity,micro-source X-ray technology. It i...ata analysis, enabling faster results even for the... diffraction is used to determine the structure of...

Other Biology Technology:Trusted LASIK Surgeons Welcomes Mobile Alabama Expert Refractive Eye Surgeon Richard Duffey, M.D. to Its LASIK Directory For Consumers 2 Trusted LASIK Surgeons Welcomes Mobile Alabama Expert Refractive Eye Surgeon Richard Duffey, M.D. to Its LASIK Directory For Consumers 3 Trusted LASIK Surgeons Welcomes Mobile Alabama Expert Refractive Eye Surgeon Richard Duffey, M.D. to Its LASIK Directory For Consumers 4 Trusted LASIK Surgeons Welcomes Mobile Alabama Expert Refractive Eye Surgeon Richard Duffey, M.D. to Its LASIK Directory For Consumers 5 Trusted LASIK Surgeons Welcomes Mobile Alabama Expert Refractive Eye Surgeon Richard Duffey, M.D. to Its LASIK Directory For Consumers 6 New Dual Wavelength X-ray Diffractometer From Oxford Diffraction, Now a Part of Varian, Inc., Allows Increased Throughput for Challenging Single Crystal Analyses 2

Trusted LASIK Surgeons Welcomes Mobile Alabama Expert Refractive Eye Surgeon Richard Duffey, M.D. to Its LASIK Directory For Consumers Mymetics Corporation Important Shareholders Information Conference Call New Dual Wavelength X-ray Diffractometer From Oxford Diffraction, Now a Part of Varian, Inc., Allows Increased Throughput for Challenging Single Crystal Analyses

T7 RNA Polymerase from Invitrogen

T7 RNA polymerase from Chimerx

Hexokinase/ Glucose-6-Phosphate Dehydrogenase from Roche Applied Science

RNase H from Roche Applied Science

Biology Products:

T7 RNA Polymerase from Invitrogen T7 RNA polymerase from Chimerx Hexokinase/ Glucose-6-Phosphate Dehydrogenase from Roche Applied Science RNase H from Roche Applied Science

BIO-key(R) Reports Profitability on Strong Revenue Growth for Second Qu...(d using the pass code 11117487#. Additio...)